Respiratory syncytial virus infection and the need for immunization in Korea

References

• Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588–598.
   PubMed Web of Science ®Google Scholar
• Troeger C, Blacker B, Khalil IA, GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1191–1210.
   PubMed Web of Science ®Google Scholar
• Caballero MT, Polack FP, Stein RT. Viral bronchiolitis in young infants: new perspectives for management and treatment. J Pediatr (Rio J). 2017;93(Suppl 1):75–83.
   PubMedGoogle Scholar
• Shi T, McAllister DA, O’Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946–958.
   PubMed Web of Science ®Google Scholar
• Falsey AR, Hennessey PA, Formica MA, et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749–1759.
   PubMed Web of Science ®Google Scholar
• Jansen AG, Sanders EA, Hoes AW, et al. Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J. 2007;30(6):1158–1166.
   PubMed Web of Science ®Google Scholar
• Falsey AR, McElhaney JE, Beran J, et al. Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness. J Infect Dis. 2014;209(12):1873–1881.
   PubMed Web of Science ®Google Scholar
• Belongia EA, King JP, Kieke BA, et al. Clinical features, severity, and incidence of RSV illness during 12 consecutive seasons in a community cohort of adults ≥60 years old. Open Forum Infect Dis. 2018;5(12):ofy316.
   PubMed Web of Science ®Google Scholar
• Hall CB, Simőes EA, Anderson LJ. Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol. 2013;372:39–57.
   PubMed Web of Science ®Google Scholar
• Widmer K, Griffin MR, Zhu Y, et al. Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults. Influenza Other Respir Viruses. 2014;8(3):347–352.
   PubMed Web of Science ®Google Scholar
• Rima B, Collins P, Easton A, et al. ICTV virus taxonomy profile: pneumoviridae. J Gen Virol. 2017;98(12):2912–2913.
   PubMed Web of Science ®Google Scholar
• Borchers AT, Chang C, Gershwin ME, et al. Respiratory syncytial virus-a comprehensive review. Clin Rev Allergy Immunol. 2013;45(3):331–379.
   PubMed Web of Science ®Google Scholar
• Griffiths C, Drews SJ, Marchant DJ. Respiratory syncytial virus: infection, detection, and new options for prevention and treatment. Clin Microbiol Rev. 2017;30(1):277–319.
   PubMed Web of Science ®Google Scholar
• Vandini S, Biagi C, Lanari M. Respiratory syncytial virus: the influence of serotype and genotype variability on clinical course of infection. Int J Mol Sci. 2017;18(8):1717.
   PubMed Web of Science ®Google Scholar
• Choi EH, Lee HJ. Genetic diversity and molecular epidemiology of the G protein of subgroups A and B of respiratory syncytial viruses isolated over 9 consecutive epidemics in Korea. J Infect Dis. 2000;181(5):1547–1556.
   PubMed Web of Science ®Google Scholar
• Kulkarni H, Smith CM, Lee Ddo H, et al. Evidence of respiratory syncytial virus spread by aerosol. time to revisit infection control strategies? Am J Respir Crit Care Med. 2016;194(3):308–316.
   PubMed Web of Science ®Google Scholar
• Otomaru H, Kamigaki T, Tamaki R, et al. Transmission of respiratory syncytial virus among children under 5 years in households of rural communities, the Philippines. Open Forum Infect Dis. 2019;6(3):ofz045.
   PubMed Web of Science ®Google Scholar
• van Boven M, Teirlinck AC, Meijer A, et al. Estimating transmission parameters for respiratory syncytial virus and predicting the impact of maternal and pediatric vaccination. J Infect Dis. 2020;222(Suppl 7):S688–S694.
   PubMedGoogle Scholar
• Pangesti KNA, El Ghany MA, Kesson AM, et al. Respiratory syncytial virus in the Western Pacific Region: a systematic review and meta-analysis. J Glob Health. 2019;9(2):020431.
   PubMed Web of Science ®Google Scholar
• Glezen WP, Taber LH, Frank AL, et al. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140(6):543–546.
   PubMedGoogle Scholar
• Henderson FW, Collier AM, Clyde WA Jr, et al. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med. 1979;300(10):530–534.
   PubMed Web of Science ®Google Scholar
• Tin Tin Htar M, Yerramalla MS, Moïsi JC, et al. The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis. Epidemiol Infect. 2020;148:e48.
   PubMed Web of Science ®Google Scholar
• Nam HH, Ison MG. Respiratory syncytial virus infection in adults. BMJ. 2019;366:l5021.
   PubMedGoogle Scholar
• Smith DK, Seales S, Budzik C. Respiratory syncytial virus bronchiolitis in children. Am Fam Physician. 2017;95(2):94–99.
   PubMed Web of Science ®Google Scholar
• Stein RT, Bont LJ, Zar H, et al. Respiratory syncytial virus hospitalization and mortality: systematic review and meta-analysis. Pediatr Pulmonol. 2017;52(4):556–569.
   PubMed Web of Science ®Google Scholar
• Kenmoe S, Kengne-Nde C, Modiyinji AF, et al. Comparison of health care resource utilization among preterm and term infants hospitalized with human respiratory syncytial virus infections: a systematic review and meta-analysis of retrospective cohort studies. PLoS One. 2020;15(2):e0229357.
   PubMed Web of Science ®Google Scholar
• Scheltema NM, Gentile A, Lucion F, et al. Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series. Lancet Glob Health. 2017;5(10):e984–e991.
   PubMed Web of Science ®Google Scholar
• Lee N, Lui GC, Wong KT, et al. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis. 2013;57(8):1069–1077.
   PubMed Web of Science ®Google Scholar
• Mehta J, Walsh EE, Mahadevia PJ, et al. Risk factors for respiratory syncytial virus illness among patients with chronic obstructive pulmonary disease. Copd. 2013;10(3):293–299.
   PubMedGoogle Scholar
• Park SY, Kim T, Jang YR, et al. Factors predicting life-threatening infections with respiratory syncytial virus in adult patients. Infect Dis (Lond). 2017;49(5):333–340.
   PubMed Web of Science ®Google Scholar
• Ivey KS, Edwards KM, Talbot HK. Respiratory syncytial virus and associations with cardiovascular disease in adults. J Am Coll Cardiol. 2018;71(14):1574–1583.
   PubMed Web of Science ®Google Scholar
• Bont L, Checchia PA, Fauroux B, et al. Defining the epidemiology and burden of severe respiratory syncytial virus infection among infants and children in Western countries. Infect Dis Ther. 2016;5(3):271–298.
   PubMed Web of Science ®Google Scholar
• Caballero MT, Polack FP. Respiratory syncytial virus is an “opportunistic” killer. Pediatr Pulmonol. 2018;53(5):664–667.
   PubMed Web of Science ®Google Scholar
• Blanken MO, Rovers MM, Molenaar JM, et al. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med. 2013;368(19):1791–1799.
   PubMed Web of Science ®Google Scholar
• Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010;65(12):1045–1052.
   PubMed Web of Science ®Google Scholar
• Peña M, Jara C, Flores JC, et al. Severe respiratory disease caused by human respiratory syncytial virus impairs language learning during early infancy. Sci Rep. 2020;10(1):22356.
   PubMed Web of Science ®Google Scholar
• Yoon SW, Kim HJ, Yum MK, et al. Neurologic complications associated with respiratory syncytial virus infection in childhood. J Korean Child Neurol Soc. 2008;16(2):206–212.
   Google Scholar
• Cha T, Choi YJ, Oh JW, et al. Respiratory syncytial virus-associated seizures in Korean children, 2011-2016. Korean J Pediatr. 2019;62(4):131–137.
   PubMedGoogle Scholar
• Sweetman LL, Ng YT, Butler IJ, et al. Neurologic complications associated with respiratory syncytial virus. Pediatr Neurol. 2005;32(5):307–310.
   PubMed Web of Science ®Google Scholar
• Millichap JJ, Wainwright MS. Neurological complications of respiratory syncytial virus infection: case series and review of literature. J Child Neurol. 2009;24(12):1499–1503.
   PubMed Web of Science ®Google Scholar
• Smithgall M, Maykowski P, Zachariah P, et al. Epidemiology, clinical features, and resource utilization associated with respiratory syncytial virus in the community and hospital. Influenza Other Respir Viruses. 2020;14(3):247–256.
   PubMed Web of Science ®Google Scholar
• Shi T, Balsells E, Wastnedge E, et al. Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: systematic review and meta-analysis. J Glob Health. 2015;5(2):020416.
   PubMed Web of Science ®Google Scholar
• Jung JW. Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey. Korean J Pediatr. 2011;54(5):192–196.
   PubMedGoogle Scholar
• Walsh EE, Falsey AR. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults. J Infect Dis. 2004;190(2):373–378.
   PubMed Web of Science ®Google Scholar
• Falsey AR, Walsh EE. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults. J Infect Dis. 1998;177(2):463–466.
   PubMed Web of Science ®Google Scholar
• IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102(3 Pt 1):531–537.
   Web of Science ®Google Scholar
• Brady MT, Byington CL, Davies HD, American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134(2):415–420.
   PubMedGoogle Scholar
• Min SJ, Song JS, Choi JH, et al. Analysis of palivizumab prophylaxis in patients with acute lower respiratory tract infection caused by respiratory syncytial virus. Korean J Pediatr Infect Dis. 2011;18(2):154–162.
   Google Scholar
• Hammitt LL, Dagan R, Yuan Y, et al. MELODY Study Group. Nirsevimab for prevention of RSV in healthy late-preterm and term infants. N Engl J Med. 2022;386:837–846. 9
   PubMed Web of Science ®Google Scholar
• KDCA (Korea Centers for Disease Control and Prevention) infectious disease portal. Available from: http://www.kdca.go.kr/npt/biz/npp/portal/nppLwcrIcdMain.do (Cited 2022 Jun 10
   Google Scholar
• Kim JM, Jung HD, Cheong HM, et al. Nation-wide surveillance of human acute respiratory virus infections between 2013 and 2015 in Korea. J Med Virol. 2018;90(7):1177–1183.
   PubMed Web of Science ®Google Scholar
• Kim JK, Jeon JS, Kim JW, et al. Epidemiology of respiratory viral infection using multiplex rt-PCR in Cheonan, Korea (2006-2010). J Microbiol Biotechnol. 2013;23(2):267–273.
   PubMed Web of Science ®Google Scholar
• Ko DH, Hyun J, Kim HS, et al. Analysis of respiratory viral infections detected using multiplex real-time PCR in Hwaseong, Korea from 2013 to 2015. Clin Lab. 2017;63(5):1003–1007.
   PubMed Web of Science ®Google Scholar
• Kim SH, Huh JH, Bae SY, et al. Epidemiology of respiratory viral infection in 2004-2006. Korean J Lab Med. 2006;26(5):351–357.
   PubMedGoogle Scholar
• Kim GY, Rheem I, Joung YH, et al. Investigation of occurrence patterns of respiratory syncytial virus A and B in infected-patients from Cheonan, Korea. Respir Res. 2020;21(1):191.
   PubMed Web of Science ®Google Scholar
• Choi HS, Kim MN, Sung H, et al. Laboratory-based surveillance of hospital-acquired respiratory virus infection in a tertiary care hospital. Am J Infect Control. 2017;45(5):e45–e47.
   PubMed Web of Science ®Google Scholar
• Park E, Park PH, Huh JW, et al. Molecular and clinical characterization of human respiratory syncytial virus in South Korea between 2009 and 2014. Epidemiol Infect. 2017;145(15):3226–3242.
   PubMed Web of Science ®Google Scholar
• Yun BY, Kim MR, Park JY, et al. Viral etiology and epidemiology of acute lower respiratory tract infections in Korean children. Pediatr Infect Dis J. 1995;14(12):1054–1059.
   PubMed Web of Science ®Google Scholar
• Ahn KM, Chung SH, Chung EH, et al. Clinical characteristics of acute viral lower respiratory tract infections in hospitalized children in Seoul, 1996-1998. J Korean Med Sci. 1999;14(4):405–411.
   PubMed Web of Science ®Google Scholar
• Kim MR, Lee HR, Lee GM. Epidemiology of acute viral respiratory tract infections in Korean children. J Infect. 2000;41(2):152–158.
   PubMed Web of Science ®Google Scholar
• Choi EH, Lee HJ, Kim SJ, et al. The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005. Clin Infect Dis. 2006;43(5):585–592.
   PubMed Web of Science ®Google Scholar
• Kim YK, Nyambat B, Hong YS, et al. Burden of viral respiratory disease hospitalizations among children in a community of Seoul, Republic of Korea, 1995-2005. Scand J Infect Dis. 2008;40(11–12):946–953.
   PubMed Web of Science ®Google Scholar
• Chun JK, Lee JH, Kim HS, et al. Establishing a surveillance network for severe lower respiratory tract infections in Korean infants and young children. Eur J Clin Microbiol Infect Dis. 2009;28(7):841–844.
   PubMed Web of Science ®Google Scholar
• Baek YH, Choi EH, Song MS, et al. Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea. Arch Virol. 2012;157(6):1039–1050.
   PubMed Web of Science ®Google Scholar
• Seo YB, Cheong HJ, Song JY, et al. Epidemiologic differences of four major respiratory viruses between children, adolescents, and adults in Korea. J Infect Chemother. 2014;20(11):672–677.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Shim SY, Son DW, et al. Respiratory viruses in neonates hospitalized with acute lower respiratory tract infections. Pediatr Int. 2013;55(1):49–53.
   PubMed Web of Science ®Google Scholar
• Kwon JM, Shim JW, Kim DS, et al. Prevalence of respiratory viral infection in children hospitalized for acute lower respiratory tract diseases, and association of rhinovirus and influenza virus with asthma exacerbations. Korean J Pediatr. 2014;57(1):29–34.
   PubMedGoogle Scholar
• Seo YB, Song JY, Choi MJ, et al. Etiology and clinical outcomes of acute respiratory virus infection in hospitalized adults. Infect Chemother. 2014;46(2):67–76.
   PubMedGoogle Scholar
• Choi E, Ha KS, Song DJ, et al. Clinical and laboratory profiles of hospitalized children with acute respiratory virus infection. Korean J Pediatr. 2018;61(6):180–186.
   PubMedGoogle Scholar
• Lee E, Kim CH, Lee YJ, et al. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea. BMC Infect Dis. 2020;20(1):132.
   PubMed Web of Science ®Google Scholar
• Chung JY, Han TH, Kim SW, et al. Detection of viruses identified recently in children with acute wheezing. J Med Virol. 2007;79(8):1238–1243.
   PubMed Web of Science ®Google Scholar
• Kim CK, Choi J, Callaway Z, et al. Clinical and epidemiological comparison of human metapneumovirus and respiratory syncytial virus in Seoul, Korea, 2003-2008. J Korean Med Sci. 2010;25(3):342–347.
   PubMed Web of Science ®Google Scholar
• Lee JH, Chang YS, Committee on Data Collection and Statistical Analysis, the Korean Society of Neonatology. Use of medical resources by preterm infants born at less than 33 weeks’ gestation following discharge from the neonatal intensive care unit in Korea. J Korean Med Sci. 2015;30(Suppl 1):S95–S103.
   PubMedGoogle Scholar
• Kang JM, Lee J, Kim YK, et al. Pediatric intensive care unit admission due to respiratory syncytial virus: retrospective multicenter study. Pediatr Int. 2019;61(7):688–696.
   PubMed Web of Science ®Google Scholar
• Park HW, Lee BS, Kim AR, et al. Epidemiology of respiratory syncytial virus infection in infants born at less than thirty-five weeks of gestational age. Pediatr Infect Dis J. 2012;31(8):e99–104.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim CS, Chang YS, et al. Respiratory syncytial virus related readmission in preterm infants less than 34 weeks’ gestation following discharge from a neonatal intensive care unit in Korea. J Korean Med Sci. 2015;30(Suppl1):S104–S110.
   PubMedGoogle Scholar
• Park SK, Jung YJ, Yoo HS, et al. Effect of Synagis® (palivizumab) prophylaxis on readmission due to respiratory syncytial virus in very low birth weight infants. Korean J Pediatr. 2010;53(3):358–363.
   Google Scholar
• Chang SG, Park MS, Yu JE. Outcomes of palivizumab prophylaxis for respiratory syncytial virus infection in preterm children with bronchopulmonary dysplasia at a single hospital in Korea from 2005 to 2009. J Korean Med Sci. 2010;25(2):251–256.
   PubMed Web of Science ®Google Scholar
• Han YM, Seo HJ, Choi SH, et al. Effect of prophylactic palivizumab on admission due to respiratory syncytial virus infection in former very low birth weight infants with bronchopulmonary dysplasia. J Korean Med Sci. 2015;30(7):924–931.
   PubMed Web of Science ®Google Scholar
• Shim WS, Lee JY, Song JY, et al. Respiratory syncytial virus infection cases in congenital heart disease patients. Korean J Pediatr. 2010;53(3):380–391.
   Google Scholar
• Kim AY, Jung SY, Choi JY, et al. Retrospective multicenter study of respiratory syncytial virus prophylaxis in Korean children with congenital heart diseases. Korean Circ J. 2016;46(5):719–726.
   PubMed Web of Science ®Google Scholar
• Ryu S, Kim BI, Chun BC. An outbreak of respiratory tract infection due to respiratory syncytial virus-B in a postpartum center. J Infect Chemother. 2018;24(9):689–694.
   PubMed Web of Science ®Google Scholar
• Kang JO, Kim CR. Nosocomial respiratory syncytial virus infection in a newborn nursery. J Korean Med Sci. 1997;12(6):489–491.
   PubMedGoogle Scholar
• Chang SH, Jang GC, Yoon SW. Clinical features of respiratory syncytial virus infection in neonates: a single center study. Neonatal Med. 2018;25(4)144–152.
   Google Scholar
• Kim YK, Choi EH, Lee HJ. Genetic variability of the fusion protein and circulation patterns of genotypes of the respiratory syncytial virus. J Med Virol. 2007;79(6):820–828.
   PubMed Web of Science ®Google Scholar
• Yun KW, Choi EH, Lee HJ. Molecular epidemiology of respiratory syncytial virus for 28 consecutive seasons (1990-2018) and genetic variability of the duplication region in the G gene of genotypes ON1 and BA in South Korea. Arch Virol. 2020;165(5):1069–1077.
   PubMed Web of Science ®Google Scholar
• Kwon YS, Park SH, Kim MA, et al. Risk of mortality associated with respiratory syncytial virus and influenza infection in adults. BMC Infect Dis. 2017;17(1):785.
   PubMedGoogle Scholar
• Noh JY, Song JY, Cheong HJ, et al. Laboratory surveillance of influenza-like illness in seven teaching hospitals, South Korea: 2011-2012 season. PLoS One. 2013;8(5):e64295.
   PubMed Web of Science ®Google Scholar
• Choi SH, Hong SB, Ko GB, et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med. 2012;186(4):325–332.
   PubMed Web of Science ®Google Scholar
• Hong HL, Hong SB, Ko GB, et al. Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia. PLoS One. 2014;9(4):e95865.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Choi SM, Lee J, et al. Respiratory virus of severe pneumonia in South Korea: prevalence and clinical implications. PLoS One. 2018;13(6):e0198902.
   PubMed Web of Science ®Google Scholar
• Seo KH, Bae DJ, Kim JN, et al. Prevalence of respiratory viral infections in Korean adult asthmatics with acute exacerbations: comparison with those with stable state. Allergy Asthma Immunol Res. 2017;9(6):491–498.
   PubMed Web of Science ®Google Scholar
• Yoon JG, Noh JY, Choi WS, et al. Clinical characteristics and disease burden of respiratory syncytial virus infection among hospitalized adults. Sci Rep. 2020;10(1):12106.
   PubMed Web of Science ®Google Scholar
• Park WJ, Yoo SJ, Lee SH, et al. Respiratory syncytial virus outbreak in the basic military training cAMP of the Republic of Korea Air Force. J Prev Med Public Health. 2015;48(1):10–17.
   PubMedGoogle Scholar
• Park WJ. Seroprevalence of respiratory syncytial virus IgG among healthy young adults in basic training for the Republic of Korea Air Force. J Korean Med Sci. 2014;29(9):1325–1327.
   PubMed Web of Science ®Google Scholar
• Kim JY, Chang J. In hot pursuit of the first vaccine against respiratory syncytial virus. Yonsei Med J. 2016;57(4):809–816.
   PubMed Web of Science ®Google Scholar
• Mejias A, Rodríguez-Fernández R, Oliva S, et al. The journey to a respiratory syncytial virus vaccine. Ann Allergy Asthma Immunol. 2020;125(1):36–46.
   PubMed Web of Science ®Google Scholar
• Green CA, Drysdale SB, Pollard AJ, et al. Vaccination against respiratory syncytial virus. Interdiscip Top Gerontol Geriatr. 2020;43:182–192.
   PubMedGoogle Scholar
• Park JJ, Choi DJ. Current status of heart failure: global and Korea. Korean J Intern Med. 2020;35(3):487–497.
   PubMed Web of Science ®Google Scholar
• Biagi C, Dondi A, Scarpini S, et al. Current state and challenges in developing respiratory syncytial virus vaccines. Vaccines (Basel). 2020;8(4):672.
   PubMed Web of Science ®Google Scholar
• Giersing BK, Karron RA, Vekemans J, et al. Meeting report: WHO consultation on respiratory syncytial virus (RSV) vaccine development, Geneva, 25-26 April 2016. Vaccine. 2019;37(50):7355–7362.
   PubMed Web of Science ®Google Scholar
• Prepare Study Group, Madhi SA, Polack FP, Piedra PA, et al. Respiratory syncytial virus vaccination during pregnancy and effects in infants. N Engl J Med. 2020;383(5):426–439.
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Davis MG, Steenackers K, et al. Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults: phase I/II randomized clinical trial. J Infect Dis. 2022 Jul 29:jiac327. DOI:10.1093/infdis/jiac327.
   Web of Science ®Google Scholar
• GSK. GSK’s respiratory syncytial virus older adult vaccine candidate granted priority review by US FDA [ Cited 2023 Jan 9]. Available from: https://www.gsk.com/en-gb/media/press-releases/gsk-s-rsv-oa-vaccine-candidate-granted-priority-review-by-us-fda/
   Google Scholar